阿斯利康任命公司内部人士Rick Suarez为其美国生物制药部门主管,领导该制药商此前宣布的在美国投资500亿美元进行研发和生产的计划。该计划包括在弗吉尼亚州建造一座价值45亿美元的生产设施,这是阿斯利康在全球范围内最大规模的单笔生产投资。
阿斯利康任命公司内部人士Rick Suarez为其美国生物制药部门主管,领导该制药商此前宣布的在美国投资500亿美元进行研发和生产的计划。该计划包括在弗吉尼亚州建造一座价值45亿美元的生产设施,这是阿斯利康在全球范围内最大规模的单笔生产投资。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.